NasdaqCM - Delayed Quote USD
Bolt Biotherapeutics, Inc. (BOLT)
0.3610
+0.0200
+(5.87%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-61,289
-61,289
-69,525
-76,504
-57,066
Investing Cash Flow
57,576
57,576
71,038
57,862
-232,201
Financing Cash Flow
108
108
253
503
311,108
End Cash Position
8,970
8,970
12,575
10,809
28,948
Capital Expenditure
-41
-41
-206
-1,953
-2,338
Issuance of Capital Stock
108
108
253
503
311,108
Free Cash Flow
-61,330
-61,330
-69,731
-78,457
-59,404
12/31/2021 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.7800
+7.23%
PMVP PMV Pharmaceuticals, Inc.
1.0800
-1.82%
ANTX AN2 Therapeutics, Inc.
1.3150
+5.20%
IPSC Century Therapeutics, Inc.
0.5400
0.00%
SPRO Spero Therapeutics, Inc.
0.7322
+0.99%
LVTX LAVA Therapeutics N.V.
1.3800
-0.72%
KZR Kezar Life Sciences, Inc.
4.5000
+8.43%
NERV Minerva Neurosciences, Inc.
1.7100
+2.40%
SEER Seer, Inc.
2.0900
+6.09%
RPTX Repare Therapeutics Inc.
1.3700
+14.17%